{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T16:21:02Z","timestamp":1764433262835},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T00:00:00Z","timestamp":1564704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T00:00:00Z","timestamp":1564704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tube-forming growth is an essential histological feature of pancreatic duct adenocarcinoma (PDAC) and of the pancreatic duct epithelium; nevertheless, the nature of the signals that start to form the tubular structures remains unknown. Here, we showed the clonal growth of PDAC cell lines in a three-dimensional (3D) culture experiment that modeled the clonal growth of PDAC. At the beginning of this study, we isolated the sphere- and tube-forming clones from established mouse pancreatic cancer cell lines via limiting dilution culture using collagen gel. Compared with cells in spherical structures, the cells in the formed tubes exhibited a lower CK19 expression in 3D culture and in the tumor that grew in the abdominal cavity of nude mice. Conversely, the expression of the transforming growth factor \u03b2 (TGF-\u03b2)-signaling target mRNAs was higher in the formed tube vs the spherical structures, suggesting that TGF-\u03b2 signaling is more active in the tube-forming process than the sphere-forming process. Treatment of sphere-forming clones with TGF-\u03b21 induced tube-forming growth, upregulated the TGF-\u03b2-signaling target mRNAs, and yielded electron microscopic findings of a fading epithelial phenotype. In contrast, the elimination of TGF-\u03b2-signaling activation by treatment with inhibitors diminished the tube-forming growth and suppressed the expression of the TGF-\u03b2-signaling target mRNAs. Moreover, upregulation of the Fn1, Mmp2, and Snai1 mRNAs, which are hallmarks of tube-forming growth in PDAC, was demonstrated in a mouse model of carcinogenesis showing rapid progression because of the aggressive invasion of tube-forming cancer. Our study suggests that the tube-forming growth of PDAC relies on the activation of TGF-\u03b2 signaling and highlights the importance of the formation of tube structures.<\/jats:p>","DOI":"10.1038\/s41598-019-47101-y","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T11:19:54Z","timestamp":1564744794000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["TGF-\u03b2 signaling promotes tube-structure-forming growth in pancreatic duct adenocarcinoma"],"prefix":"10.1038","volume":"9","author":[{"given":"Takashi","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanae","family":"Ikehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Akimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayao","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Kume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzuru","family":"Ikehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,2]]},"reference":[{"key":"47101_CR1","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1056\/NEJMra0901557","volume":"362","author":"M Hidalgo","year":"2010","unstructured":"Hidalgo, M. Pancreatic cancer. N Engl J Med 362, 1605\u20131617, https:\/\/doi.org\/10.1056\/NEJMra0901557 (2010).","journal-title":"N Engl J Med"},{"key":"47101_CR2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","volume":"378","author":"A Vincent","year":"2011","unstructured":"Vincent, A., Herman, J., Schulick, R., Hruban, R. H. & Goggins, M. Pancreatic cancer. Lancet 378, 607\u2013620, https:\/\/doi.org\/10.1016\/S0140-6736(10)62307-0 (2011).","journal-title":"Lancet"},{"key":"47101_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","volume":"388","author":"T Kamisawa","year":"2016","unstructured":"Kamisawa, T., Wood, L. D., Itoi, T. & Takaori, K. Pancreatic cancer. Lancet 388, 73\u201385, https:\/\/doi.org\/10.1016\/S0140-6736(16)00141-0 (2016).","journal-title":"Lancet"},{"key":"47101_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. CA Cancer J Clin 68, 7\u201330, https:\/\/doi.org\/10.3322\/caac.21442 (2018).","journal-title":"CA Cancer J Clin"},{"key":"47101_CR5","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/S0016-5085(03)00389-5","volume":"124","author":"FXA Real","year":"2003","unstructured":"Real, F. X. A. \u201ccatastrophic hypothesis\u201d for pancreas cancer progression. Gastroenterology 124, 1958\u20131964 (2003).","journal-title":"Gastroenterology"},{"key":"47101_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ccell.2015.09.020","volume":"28","author":"AV Biankin","year":"2015","unstructured":"Biankin, A. V. & Maitra, A. Subtyping Pancreatic Cancer. Cancer Cell 28, 411\u2013413, https:\/\/doi.org\/10.1016\/j.ccell.2015.09.020 (2015).","journal-title":"Cancer Cell"},{"key":"47101_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature11547","volume":"491","author":"AV Biankin","year":"2012","unstructured":"Biankin, A. V. et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491, 399\u2013405, https:\/\/doi.org\/10.1038\/nature11547 (2012).","journal-title":"Nature"},{"key":"47101_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature14169","volume":"518","author":"N Waddell","year":"2015","unstructured":"Waddell, N. et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518, 495\u2013501, https:\/\/doi.org\/10.1038\/nature14169 (2015).","journal-title":"Nature"},{"key":"47101_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7744","volume":"6","author":"AK Witkiewicz","year":"2015","unstructured":"Witkiewicz, A. K. et al. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets. Nat Commun 6, 6744, https:\/\/doi.org\/10.1038\/ncomms7744 (2015).","journal-title":"Nat Commun"},{"key":"47101_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey, P. et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531, 47\u201352, https:\/\/doi.org\/10.1038\/nature16965 (2016).","journal-title":"Nature"},{"key":"47101_CR11","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm.2344","volume":"17","author":"EA Collisson","year":"2011","unstructured":"Collisson, E. A. et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat Med 17, 500\u2013503, https:\/\/doi.org\/10.1038\/nm.2344 (2011).","journal-title":"Nat Med"},{"key":"47101_CR12","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/ng.3398","volume":"47","author":"RA Moffitt","year":"2015","unstructured":"Moffitt, R. A. et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat Genet 47, 1168\u20131178, https:\/\/doi.org\/10.1038\/ng.3398 (2015).","journal-title":"Nat Genet"},{"key":"47101_CR13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nm.4038","volume":"22","author":"EM Noll","year":"2016","unstructured":"Noll, E. M. et al. CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma. Nat Med 22, 278\u2013287, https:\/\/doi.org\/10.1038\/nm.4038 (2016).","journal-title":"Nat Med"},{"key":"47101_CR14","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","volume":"160","author":"SF Boj","year":"2015","unstructured":"Boj, S. F. et al. Organoid models of human and mouse ductal pancreatic cancer. Cell 160, 324\u2013338, https:\/\/doi.org\/10.1016\/j.cell.2014.12.021 (2015).","journal-title":"Cell"},{"key":"47101_CR15","first-page":"2005","volume":"63","author":"FH Brembeck","year":"2003","unstructured":"Brembeck, F. H. et al. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice. Cancer Res 63, 2005\u20132009 (2003).","journal-title":"Cancer Res"},{"key":"47101_CR16","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1038\/nprot.2016.097","volume":"11","author":"L Broutier","year":"2016","unstructured":"Broutier, L. et al. Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation. Nat Protoc 11, 1724\u20131743, https:\/\/doi.org\/10.1038\/nprot.2016.097 (2016).","journal-title":"Nat Protoc"},{"key":"47101_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1136\/gutjnl-2016-312423","volume":"66","author":"M Hohwieler","year":"2017","unstructured":"Hohwieler, M. et al. Human pluripotent stem cell-derived acinar\/ductal organoids generate human pancreas upon orthotopic transplantation and allow disease modelling. Gut 66, 473\u2013486, https:\/\/doi.org\/10.1136\/gutjnl-2016-312423 (2017).","journal-title":"Gut"},{"key":"47101_CR18","doi-asserted-by":"publisher","first-page":"1247125","DOI":"10.1126\/science.1247125","volume":"345","author":"MA Lancaster","year":"2014","unstructured":"Lancaster, M. A. & Knoblich, J. A. Organogenesis in a dish: modeling development and disease using organoid technologies. Science 345, 1247125, https:\/\/doi.org\/10.1126\/science.1247125 (2014).","journal-title":"Science"},{"key":"47101_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14686","volume":"8","author":"J Lee","year":"2017","unstructured":"Lee, J. et al. Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells. Nat Commun 8, 14686, https:\/\/doi.org\/10.1038\/ncomms14686 (2017).","journal-title":"Nat Commun"},{"issue":"454\u2013467","key":"47101_CR20","doi-asserted-by":"publisher","first-page":"e456","DOI":"10.1016\/j.stem.2017.12.009","volume":"22","author":"T Seino","year":"2018","unstructured":"Seino, T. et al. Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression. Cell Stem Cell 22(454\u2013467), e456, https:\/\/doi.org\/10.1016\/j.stem.2017.12.009 (2018).","journal-title":"Cell Stem Cell"},{"key":"47101_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/path.4402","volume":"234","author":"T Yamaguchi","year":"2014","unstructured":"Yamaguchi, T., Ikehara, S., Nakanishi, H. & Ikehara, Y. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma. J Pathol 234, 228\u2013238, https:\/\/doi.org\/10.1002\/path.4402 (2014).","journal-title":"J Pathol"},{"key":"47101_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-213X-7-7","volume":"7","author":"R Montesano","year":"2007","unstructured":"Montesano, R., Carrozzino, F. & Soulie, P. Low concentrations of transforming growth factor-beta-1 induce tubulogenesis in cultured mammary epithelial cells. BMC Dev Biol 7, 7, https:\/\/doi.org\/10.1186\/1471-213X-7-7 (2007).","journal-title":"BMC Dev Biol"},{"key":"47101_CR23","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1111\/j.1742-4658.2008.06353.x","volume":"275","author":"T Yamaguchi","year":"2008","unstructured":"Yamaguchi, T. et al. Development of a new method for isolation and long-term culture of organ-specific blood vascular and lymphatic endothelial cells of the mouse. Febs J 275, 1988\u20131998, https:\/\/doi.org\/10.1111\/j.1742-4658.2008.06353.x (2008).","journal-title":"Febs J"},{"key":"47101_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.abb.2016.01.012","volume":"605","author":"Y Akimoto","year":"2016","unstructured":"Akimoto, Y. et al. Galectin expression in healing wounded skin treated with low-temperature plasma: Comparison with treatment by electronical coagulation. Arch Biochem Biophys 605, 86\u201394, https:\/\/doi.org\/10.1016\/j.abb.2016.01.012 (2016).","journal-title":"Arch Biochem Biophys"},{"key":"47101_CR25","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/glycob\/cwl005","volume":"16","author":"Y Ikehara","year":"2006","unstructured":"Ikehara, Y. et al. Apical Golgi localization of N,N\u2032-diacetyllactosediamine synthase, beta4GalNAc-T3, is responsible for LacdiNAc expression on gastric mucosa. Glycobiology 16, 777\u2013785, https:\/\/doi.org\/10.1093\/glycob\/cwl005 (2006).","journal-title":"Glycobiology"},{"key":"47101_CR26","first-page":"4222","volume":"61","author":"V Ellenrieder","year":"2001","unstructured":"Ellenrieder, V. et al. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res 61, 4222\u20134228 (2001).","journal-title":"Cancer Res"},{"key":"47101_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2353\/ajpath.2010.090747","volume":"177","author":"Y Sato","year":"2010","unstructured":"Sato, Y. et al. Epithelial-mesenchymal transition induced by transforming growth factor-{beta}1\/Snail activation aggravates invasive growth of cholangiocarcinoma. Am J Pathol 177, 141\u2013152, https:\/\/doi.org\/10.2353\/ajpath.2010.090747 (2010).","journal-title":"Am J Pathol"},{"key":"47101_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cyto.2015.05.020","volume":"75","author":"S Kim","year":"2015","unstructured":"Kim, S., Lee, J., Jeon, M., Nam, S. J. & Lee, J. E. Elevated TGF-beta1 and -beta2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells. Cytokine 75, 151\u2013158, https:\/\/doi.org\/10.1016\/j.cyto.2015.05.020 (2015).","journal-title":"Cytokine"},{"key":"47101_CR29","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1016\/S0002-9440(10)64327-1","volume":"162","author":"SF Cheng","year":"2003","unstructured":"Cheng, S. F. & Lovett, D. H. Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation. Am J Pathol 162, 1937\u20131949, https:\/\/doi.org\/10.1016\/S0002-9440(10)64327-1 (2003).","journal-title":"Am J Pathol"},{"key":"47101_CR30","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.cell.2016.01.009","volume":"164","author":"CJ David","year":"2016","unstructured":"David, C. J. et al. TGF-beta Tumor Suppression through a Lethal EMT. Cell 164, 1015\u20131030, https:\/\/doi.org\/10.1016\/j.cell.2016.01.009 (2016).","journal-title":"Cell"},{"key":"47101_CR31","doi-asserted-by":"publisher","first-page":"447","DOI":"10.4161\/cam.4.3.10771","volume":"4","author":"A Ferrer-Vaquer","year":"2010","unstructured":"Ferrer-Vaquer, A., Viotti, M. & Hadjantonakis, A. K. Transitions between epithelial and mesenchymal states and the morphogenesis of the early mouse embryo. Cell Adhes Migr 4, 447\u2013457, https:\/\/doi.org\/10.4161\/cam.4.3.10771 (2010).","journal-title":"Cell Adhes Migr"},{"key":"47101_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.scr.2014.11.003","volume":"14","author":"MK Hoffding","year":"2015","unstructured":"Hoffding, M. K. & Hyttel, P. Ultrastructural visualization of the Mesenchymal-to-Epithelial Transition during reprogramming of human fibroblasts to induced pluripotent stem cells. Stem Cell Res 14, 39\u201353, https:\/\/doi.org\/10.1016\/j.scr.2014.11.003 (2015).","journal-title":"Stem Cell Res"},{"key":"47101_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cytogfr.2005.09.006","volume":"17","author":"B Bierie","year":"2006","unstructured":"Bierie, B. & Moses, H. L. TGF-beta and cancer. Cytokine Growth Factor Rev 17, 29\u201340, https:\/\/doi.org\/10.1016\/j.cytogfr.2005.09.006 (2006).","journal-title":"Cytokine Growth Factor Rev"},{"key":"47101_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cytogfr.2009.11.008","volume":"21","author":"B Bierie","year":"2010","unstructured":"Bierie, B. & Moses, H. L. Transforming growth factor beta (TGF-beta) and inflammation in cancer. Cytokine Growth Factor Rev 21, 49\u201359, https:\/\/doi.org\/10.1016\/j.cytogfr.2009.11.008 (2010).","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"47101_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/jcm6010007","volume":"6","author":"Brunella Costanza","year":"2017","unstructured":"Costanza, B., Umelo, I. A., Bellier, J., Castronovo, V. & Turtoi, A. Stromal Modulators of TGF-beta in Cancer. J Clin Med 6, https:\/\/doi.org\/10.3390\/jcm6010007 (2017).","journal-title":"Journal of Clinical Medicine"},{"key":"47101_CR36","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s10552-006-0048-0","volume":"17","author":"Y Lin","year":"2006","unstructured":"Lin, Y. et al. Serum transforming growth factor-beta1 levels and pancreatic cancer risk: a nested case-control study (Japan). Cancer Causes Control 17, 1077\u20131082, https:\/\/doi.org\/10.1007\/s10552-006-0048-0 (2006).","journal-title":"Cancer Causes Control"},{"key":"47101_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1182\/blood-2016-01-636399","volume":"128","author":"R Leblanc","year":"2016","unstructured":"Leblanc, R. & Peyruchaud, O. Metastasis: new functional implications of platelets and megakaryocytes. Blood 128, 24\u201331, https:\/\/doi.org\/10.1182\/blood-2016-01-636399 (2016).","journal-title":"Blood"},{"key":"47101_CR38","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","volume":"20","author":"M Labelle","year":"2011","unstructured":"Labelle, M., Begum, S. & Hynes, R. O. Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis. Cancer Cell 20, 576\u2013590, https:\/\/doi.org\/10.1016\/j.ccr.2011.09.009 (2011).","journal-title":"Cancer Cell"},{"key":"47101_CR39","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3978\/j.issn.2304-3881.2015.06.08","volume":"4","author":"D Ansari","year":"2015","unstructured":"Ansari, D., Ansari, D., Andersson, R. & Andren-Sandberg, A. Pancreatic cancer and thromboembolic disease, 150 years after Trousseau. Hepatobiliary Surg Nutr 4, 325\u2013335, https:\/\/doi.org\/10.3978\/j.issn.2304-3881.2015.06.08 (2015).","journal-title":"Hepatobiliary Surg Nutr"},{"key":"47101_CR40","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S1470-2045(04)01606-7","volume":"5","author":"AA Khorana","year":"2004","unstructured":"Khorana, A. A. & Fine, R. L. Pancreatic cancer and thromboembolic disease. Lancet Oncol 5, 655\u2013663, https:\/\/doi.org\/10.1016\/S1470-2045(04)01606-7 (2004).","journal-title":"Lancet Oncol"},{"key":"47101_CR41","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.celrep.2017.06.062","volume":"20","author":"JE Jang","year":"2017","unstructured":"Jang, J. E. et al. Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer. Cell Rep 20, 558\u2013571, https:\/\/doi.org\/10.1016\/j.celrep.2017.06.062 (2017).","journal-title":"Cell Rep"},{"key":"47101_CR42","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1084\/jem.20050463","volume":"202","author":"F Ghiringhelli","year":"2005","unstructured":"Ghiringhelli, F. et al. Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4(+)CD25(+) regulatory T cell proliferation. J Exp Med 202, 919\u2013929, https:\/\/doi.org\/10.1084\/jem.20050463 (2005).","journal-title":"J Exp Med"},{"key":"47101_CR43","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/S0960-9822(07)00533-7","volume":"8","author":"M Oft","year":"1998","unstructured":"Oft, M., Heider, K. H. & Beug, H. TGF beta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 8, 1243\u20131252, https:\/\/doi.org\/10.1016\/S0960-9822(07)00533-7 (1998).","journal-title":"Curr Biol"},{"key":"47101_CR44","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/nm.3973","volume":"21","author":"L Huang","year":"2015","unstructured":"Huang, L. et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids. Nat Med 21, 1364\u20131371, https:\/\/doi.org\/10.1038\/nm.3973 (2015).","journal-title":"Nat Med"},{"key":"47101_CR45","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature16064","volume":"527","author":"XF Zheng","year":"2015","unstructured":"Zheng, X. F. et al. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 527, 525\u2013+, https:\/\/doi.org\/10.1038\/nature16064 (2015).","journal-title":"Nature"},{"key":"47101_CR46","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/onc.2013.118","volume":"33","author":"J Park","year":"2014","unstructured":"Park, J. & Schwarzbauer, J. E. Mammary epithelial cell interactions with fibronectin stimulate epithelial-mesenchymal transition. Oncogene 33, 1649\u20131657, https:\/\/doi.org\/10.1038\/onc.2013.118 (2014).","journal-title":"Oncogene"},{"key":"47101_CR47","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1634\/stemcells.2007-0103","volume":"25","author":"Y Hayashi","year":"2007","unstructured":"Hayashi, Y. et al. Integrins regulate mouse embryonic stem cell self-renewal. Stem Cells 25, 3005\u20133015, https:\/\/doi.org\/10.1634\/stemcells.2007-0103 (2007).","journal-title":"Stem Cells"},{"key":"47101_CR48","first-page":"1321","volume":"48","author":"S Linder","year":"2001","unstructured":"Linder, S., Castanos-Velez, E., von Rosen, A. & Biberfeld, P. Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma. Hepatogastroenterology 48, 1321\u20131327 (2001).","journal-title":"Hepatogastroenterology"},{"key":"47101_CR49","doi-asserted-by":"publisher","first-page":"632","DOI":"10.4161\/cbt.9.8.11265","volume":"9","author":"RE Schwarz","year":"2010","unstructured":"Schwarz, R. E. et al. Antitumor effects of EMAP II against pancreatic cancer through inhibition of fibronectin-dependent proliferation. Cancer Biol Ther 9, 632\u2013639, https:\/\/doi.org\/10.4161\/cbt.9.8.11265 (2010).","journal-title":"Cancer Biol Ther"},{"key":"47101_CR50","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1245\/s10434-007-9540-3","volume":"14","author":"MM Javle","year":"2007","unstructured":"Javle, M. M. et al. Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer. Ann Surg Oncol 14, 3527\u20133533, https:\/\/doi.org\/10.1245\/s10434-007-9540-3 (2007).","journal-title":"Ann Surg Oncol"},{"key":"47101_CR51","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.stem.2014.11.001","volume":"16","author":"S Puri","year":"2015","unstructured":"Puri, S., Folias, A. E. & Hebrok, M. Plasticity and Dedifferentiation within the Pancreas: Development, Homeostasis, and Disease. Cell Stem Cell 16, 18\u201331, https:\/\/doi.org\/10.1016\/j.stem.2014.11.001 (2015).","journal-title":"Cell Stem Cell"},{"key":"47101_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/srep30904","volume":"6","author":"J Liu","year":"2016","unstructured":"Liu, J. et al. TGF-beta1 promotes acinar to ductal metaplasia of human pancreatic acinar cells. Sci Rep 6, 30904, https:\/\/doi.org\/10.1038\/srep30904 (2016).","journal-title":"Sci Rep"},{"key":"47101_CR53","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.canlet.2015.12.027","volume":"381","author":"M Topalovski","year":"2016","unstructured":"Topalovski, M. & Brekken, R. A. Matrix control of pancreatic cancer: New insights into fibronectin signaling. Cancer Lett 381, 252\u2013258, https:\/\/doi.org\/10.1016\/j.canlet.2015.12.027 (2016).","journal-title":"Cancer Lett"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47101-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47101-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47101-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T12:07:29Z","timestamp":1671278849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47101-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,2]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["47101"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-47101-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2019,8,2]]},"assertion":[{"value":"11 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11247"}}